Work

Periorbital edema and phototoxic rash associated with dasatinib: A case report

Year: 2025

Type: article

Abstract: Dasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. In this case, a phototoxic rash that developed in a 78-year-old bcr-abl positive acute lymphoblastic leukemia patient is presented. This case supports that phototoxic reactions may occur with dasatinib and emphasizes that clinicians should be alert for this side effect.

Source: SAGE Open Medical Case Reports

DOI: 10.1177/2050313x251330969

Authors: Bera Omer Ugurlu, Umit Yavuz Malkan

Institution: Hacettepe University

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000